Filter by: Subject

Filter by: Subject

Results Per Page:

SDG-03: Good health and well-being (28)
South Africa (SA) (6)
Antimicrobial resistance (AMR) (4)
Tuberculosis (TB) (4)
Coronavirus disease 2019 (COVID-19) (3)
COVID-19 pandemic (3)
Escherichia coli (3)
Human immunodeficiency virus (HIV) (3)
Multidrug-resistant (MDR) (3)
Sexually transmitted infection (STI) (3)
Women (3)
Bedaquiline (2)
Dogs (Canis familiaris) (2)
Infants (2)
Mycobacterium tuberculosis (MTB) (2)
Population-based surveillance (2)
Pre-exposure prophylaxis (PrEP) (2)
Preterm birth (2)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (2)
Sub-Saharan Africa (SSA) (2)
Whole genome sequencing (WGS) (2)
Acinetobacter baumannii (1)
Acquired immune deficiency syndrome (AIDS) (1)
Actinomycetes (1)
Adolescent girls and young women (AGYW) (1)
Adverse perinatal outcomes (1)
Africa (1)
Antibiotic resistance genes (ARGs) (1)
Antimicrobial (1)
Anti–capsular polysaccharide IgG (anti-CPS IgG) (1)
AZD1222 (1)
Bacteria (1)
Bedaquiline-pretonamid-linezolid (BPaL) (1)
Beta-lactams (1)
Biflavonoid (1)
Bloodstream infections (1)
Bloodstream infections (BSIs) (1)
Burkina Faso (BF) (1)
Canada (1)
Canonical variant (1)
Capsular polysaccharide (CPS) (1)
Cats (1)
ChAdOx1 (1)
Children (1)
Chlamydia trachomatis (1)
Cholera (1)
Clinical trials (1)
Clofazimine (CFZ) (1)
Companion animals (1)
Complications (1)
Copper intrauterine device (1)
Correspondence (1)
COVID-19 vaccine efficacy (1)
CTX-M-14 (1)
CTX-M-15 (1)
Cytotoxicity (1)
Côte d’Ivoire (CIV) (1)
Death (1)
Developing countries (1)
Diagnostic techniques and procedures (1)
Discrete choice experiment (1)
Dominant clones (1)
Doxycycline (1)
Drug sensitivity testing (1)
Enteric infections (1)
Epidemiology (1)
Escherichia coli ST131 (1)
ESKAPE (1)
Evidence for contraceptive options and HIV outcomes (ECHO) (1)
Expulsion (1)
Extended spectrum beta-lactamase (ESBL) (1)
Extended-spectrum β-lactamase (ESBL) (1)
Extraintestinal pathogenic E. coli (ExPEC) (1)
Genetic signatures (1)
Genital tract infection (1)
Genomics (1)
Genotypes (1)
Glycoconjugate vaccine (GBS6) (1)
Group B streptococcal disease (1)
Healthcare workers (HCW) (1)
HIV infection (1)
HIV prevention (1)
Hollow fiber model system (1)
Implant (1)
Implementation (1)
In vitro mutants (1)
Incidence (1)
Infection (1)
Infection prevention and control (IPC) (1)
Insertion (1)
Intrauterine device (IUD) (1)
Klebsiella pneumoniae (1)
Lineages (1)
Lipoarabinomannan (1)
Loop-mediated isothermal amplification (LAMP) (1)
Low- and middle-income countries (LMICs) (1)
Lower respiratory tract illness (LRTI) (1)
Loxostylis alata (1)
Malawi (1)
Maternal vaccine (1)